Arranon, Atriance (nelarabine) is a small molecule pharmaceutical. Nelarabine was first approved as Arranon on 2005-10-28. It is used to treat t-cell leukemia in the USA. It has been approved in Europe to treat precursor t-cell lymphoblastic leukemia-lymphoma.
|Indication||precursor t-cell lymphoblastic leukemia-lymphoma, t-cell leukemia|
|Drug Class||Antineoplastics (arabinofuranosyl derivatives)|